A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

Phase 4 Active not recruiting 50 enrolled Bristol-Myers Squibb

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.

Timeline

Start: 2025-09-04
Primary completion: 2027-12-13
Completion: 2027-12-13

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mavacamten	Small molecule	—	—

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

Summary

Timeline

Drugs

Indications